Advancing Hematologic Cancer Treatment: The Promise of CAR-T | 107120
Europäisches Journal für klinische Onkologie
ISSN - 2732-2654
Abstrakt
Advancing Hematologic Cancer Treatment: The Promise of CAR-T Cell Therapy
Albert Kevin
Hematologic malignancies, including leukemia and lymphoma, present significant challenges in oncology due to their complex biology and limited treatment options for refractory or relapsed disease